MetaADEDB 2.0 @ LMMD
fosfluconazole
(GHJWNRRCRIGGIO-UHFFFAOYSA-N)
Structure
SMILES
Fc1ccc(c(c1)F)C(OP(=O)(O)O)(Cn1cncn1)Cn1cncn1
Molecular Formula:
C13H13F2N6O4P
Molecular Weight:
386.251
Log P:
0.8528
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
2
TPSA:
137.99
CAS Number(s):
194798-83-9
Synonym(s)
1.
fosfluconazole
External Link(s)
MeSHC486878
PubChem Compound214356
ChEBI31634
CHEMBLCHEMBL1908301
DrugCentral1242
KEGGdr:D01429
ZINC3609266
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Activated partial thromboplastin time abnormalOFFSIDES
3Adrenal atrophyOFFSIDES
4Alanine Aminotransferase IncreasedOFFSIDES
5Altered state of consciousnessOFFSIDES
6AmyloidosisOFFSIDES
7Anal FistulaOFFSIDES
8AnuriaOFFSIDES
9ArteriosclerosisOFFSIDES
10AsthmaOFFSIDES
11Atrioventricular BlockOFFSIDES
12Blood albumin decreasedOFFSIDES
13Blood uric acid decreasedOFFSIDES
14Blood uric acidOFFSIDES
15BronchopneumoniaOFFSIDES
16Cardiac TamponadeOFFSIDES
17Chemotherapeutic drug level increasedOFFSIDES
18Depressed Level of ConsciousnessOFFSIDES
19Device related infectionOFFSIDES
20DiarrheaOFFSIDES
21Disease ProgressionOFFSIDES
22Disseminated Intravascular CoagulationOFFSIDES
23Diverticular perforationOFFSIDES
24Endoscopic Retrograde CholangiopancreatographyOFFSIDES
25Enterobacter sepsisOFFSIDES
26EnterocolitisOFFSIDES
27Eosinophilic PneumoniaOFFSIDES
28EpidermolysisOFFSIDES
29EpistaxisOFFSIDES
30Escherichia infectionOFFSIDES
31Fatty LiverOFFSIDES
32Febrile NeutropeniaOFFSIDES
33Fungus serology test positiveOFFSIDES
34Gastroenteritis bacillusOFFSIDES
35Gastrointestinal infectionOFFSIDES
36Gastrointestinal perforationOFFSIDES
37General physical health deteriorationOFFSIDES
38Hepatic vein occlusionOFFSIDES
39Hypercalcemia18646608CTD
40HypocomplementaemiaOFFSIDES
41HypoxiaOFFSIDES
42Intention tremorOFFSIDES
43Kidney FailureOFFSIDES
44Leukopenia neonatalOFFSIDES
45Liver transplant rejectionOFFSIDES
46Lymphocyte count decreasedOFFSIDES
47Lymphocyte stimulation test positiveOFFSIDES
48Malignant ascitesOFFSIDES
49Mental impairmentOFFSIDES
50Mouth BreathingOFFSIDES
51Neutrophil count decreasedOFFSIDES
52Pericardial effusionOFFSIDES
53PeritonitisOFFSIDES
54Pneumocystis jiroveci pneumoniaOFFSIDES
55Protein total decreasedOFFSIDES
56Prothrombin time abnormalOFFSIDES
57PyelonephritisOFFSIDES
58Renal salt-wasting syndromeOFFSIDES
59Respiratory FailureOFFSIDES
60RhabdomyosarcomaOFFSIDES
61Septic ShockOFFSIDES
62Small intestine carcinomaOFFSIDES
63StaringOFFSIDES
64StrongyloidiasisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.